APx Acquisition Corp. I(US:APXIU)2025-03-31 19:48IPO and Trust Account - The company completed its IPO on December 9, 2021, raising gross proceeds of $172.5 million from the sale of 17,250,000 units at $10.00 per unit[20]. - A total of $175.95 million was placed in a trust account, which includes $172.5 million from the IPO and $8.95 million from the private placement of warrants[23]. - As of February 27, 2023, shareholders redeemed 10,693,417 public shares for an aggregate amount of $111.35 million, leaving approximately $68.27 million in the trust account[28]. - Following the September 2023 extraordinary general meeting, 757,463 public shares were redeemed for approximately $8.27 million, leaving about $63.34 million in the trust account[34]. - Shareholders approved a Fourth Extension allowing up to twelve one-month extensions of the termination date, with a total of $125,000 deposited for each extension, resulting in $62,410,856 remaining in the Trust Account after redemptions[39]. - The Trust Account currently holds approximately $12.05 per public share, which will be available for redemption upon completion of the initial business combination[86]. - The company must complete its initial business combination within the prescribed time frame, or public shareholders may receive only $12.05 per share upon liquidation[108]. - If the company fails to complete its initial business combination, it may be forced to wind up operations and redeem public shares, which could result in shareholders receiving less than $12.05 per share[109]. - The Trust Account may be reduced below $12.05 per share if the independent directors choose not to enforce indemnification obligations against the Sponsors[131]. - The proceeds in the Trust Account are invested in U.S. government treasury obligations with a maturity of 185 days or less, which may yield negative interest rates, potentially reducing the per-share redemption amount below $12.05[132]. - If a bankruptcy petition is filed after distributing funds from the Trust Account, shareholders may face claims for recovery of distributions received[133]. Business Combination and Extensions - The company issued a first promissory note of $875,000 on February 28, 2023, to facilitate the first extension of the business combination period[29]. - On September 7, 2023, shareholders approved an extension of the business combination period, allowing for up to three one-month extensions, with a payment of $125,000 for each extension[34]. - The Fifth Extension was approved to extend the time to complete the initial business combination from December 9, 2024, to December 9, 2025, with no further Extension Payments required[42]. - A Business Combination Agreement was entered into on March 25, 2024, with OmnigenicsAI Corp and MultiplAI Health Ltd, although the acquisition of MultiplAI was later terminated[45][46]. - The Proposed Business Combination includes a merger where each ordinary share of the Company will be exchanged for one ordinary share of OmnigenicsAI[48]. - The obligations to consummate the Proposed Business Combination are subject to customary closing conditions, including shareholder approval and Nasdaq listing approval[49]. - The Business Combination Agreement may be terminated under specific conditions, including failure to obtain necessary approvals or if the Merger Effective Time does not occur by the Outside Date[55]. - Transaction Expenses incurred in connection with the Proposed Business Combination will be paid by the party incurring them, with specific caps and conditions outlined for payment responsibilities[56]. - The MultiplAI Share Purchase Agreement was entered into on March 13, 2024, for the sale and purchase of all ordinary shares of MultiplAI[58]. - The MultiplAI SPA was terminated on August 27, 2024[59]. - The company received approval to extend the time to complete the initial business combination from December 9, 2024, to December 9, 2025[68]. Financial Position and Capital Structure - The company issued 4,312,500 founder shares for a capital contribution of $25,000, equating to approximately $0.006 per share, representing 20% of the outstanding shares post-IPO[121]. - The company raised $8,950,000 from the sale of private placement warrants, each exercisable at $11.50 per share, which will be worthless if the initial business combination is not completed[121]. - As of December 31, 2024, only $120 in cash was available outside the Trust Account to fund working capital requirements, indicating a potential shortage of working capital[125]. - The company anticipates that the funds available outside the Trust Account will not be sufficient to sustain operations for the duration of the Combination Period[125]. - The company may need to rely on loans from sponsors or third parties to finance its search for a target business, with no obligation for these parties to provide such funds[126]. - The nominal purchase price for founder shares may significantly dilute the implied value of public shares if an initial business combination is consummated[122]. - The company may issue additional Class A ordinary shares or preferred shares to complete the initial business combination, which could dilute existing shareholders[204]. - The company may issue a substantial number of additional Class A ordinary shares or preferred shares to complete its initial business combination or under an employee incentive plan after completion of the initial business combination[206]. - The company amended its Articles to extend the time to complete the initial business combination from December 9, 2024, to December 9, 2025, allowing for a total period of up to 48 months after the IPO[207]. - The company’s initial shareholders beneficially own 89.2% of the issued and outstanding ordinary shares entitled to vote, which may facilitate amendments to the Articles and trust agreement[211]. - The company identified material weaknesses in its internal control over financial reporting related to errors in warrant liabilities and classification of temporary and permanent equity[217]. Risks and Challenges - The company faces significant competition from other entities, including special purpose acquisition companies and private equity groups, which may limit its ability to acquire larger target businesses[87]. - The company has no operating history or revenues, making it challenging to evaluate its ability to achieve its business objectives[93]. - If the Proposed Business Combination is terminated, the market price of the company's securities is expected to decrease significantly[95]. - The company may not hold a shareholder vote for the initial business combination, which could lead to completion even without majority public shareholder support[99]. - The ability of public shareholders to redeem shares for cash may deter potential business combination targets due to financial unattractiveness[102]. - The ongoing geopolitical tensions, including the Russia-Ukraine conflict and the Israel-Hamas conflict, have led to significant market volatility and could adversely affect the company's search for a business combination[106]. - The company may face challenges in obtaining additional financing necessary to complete its initial business combination, which could compel it to restructure or abandon the transaction[112]. - The management's ability to assess the skills and qualifications of a target business's management may be limited, potentially impacting the operations and profitability of the post-combination business[116]. - The company may incur substantial costs in investigating and negotiating business combinations that do not materialize, adversely affecting future acquisition attempts[115]. - The company may not be able to conduct thorough due diligence on potential targets as it approaches the business combination deadline, which could undermine shareholder value[105]. - The company may pursue acquisition opportunities with early-stage or financially unstable businesses, which carry inherent risks due to limited historical financial data and volatile revenues[118]. - The company may face significant economic, competitive, and regulatory risks due to a lack of diversification, which could adversely impact its operations post-business combination[146]. - Attempting to complete multiple business combinations simultaneously may increase costs and risks, potentially hindering profitability and operational success[147]. - The company may pursue complex business combinations requiring significant operational improvements, which could delay achieving desired results[148]. - Risks inherent in combining with large, complex businesses may prevent the company from implementing its strategy effectively[149]. - Conflicts of interest may arise as officers and directors allocate their time between the company and other business ventures, potentially affecting the completion of the initial business combination[159]. - The company has not adopted a policy to prevent directors and officers from having financial interests in transactions, which may lead to conflicts between their interests and those of the company[162]. Compliance and Regulatory Issues - The company received a notice from Nasdaq indicating non-compliance with continued listing criteria due to the aggregate market value of outstanding warrants being less than $1 million[169]. - Nasdaq's staff determined that the company's Compliance Plan was insufficient, leading to the initiation of procedures to delist the warrants and units[170]. - Trading of the company's securities was suspended on Nasdaq effective December 17, 2024, following the failure to complete the Business Combination by the deadline[172]. - The company intends to proceed with efforts to consummate the initial Business Combination despite the delisting from Nasdaq[174]. - The closing of the Business Combination is conditioned on the listing of the post-combination company on Nasdaq, with no guarantee of approval[184]. - Following delisting, the company's ordinary shares could be subject to penny stock regulations, impacting liquidity and trading[178]. - The anticipated delisting may lead to reduced visibility, liquidity, and value of the company's securities, potentially harming business combination efforts[180]. - The company may face additional state regulations due to the loss of "covered securities" status following delisting[183]. - The company believes it can meet Nasdaq's initial listing requirements upon consummation of the Business Combination, but there is no guarantee[176]. - The company may be deemed an investment company under the Investment Company Act, which could severely restrict its activities and lead to liquidation[191]. Shareholder Rights and Interests - Holders of public shares will not have voting rights on the appointment of directors prior to the initial business combination[186]. - Shareholders holding over 15% of Class A ordinary shares will lose the ability to redeem shares exceeding this threshold without prior consent[187]. - Shareholders may be held liable for claims against the company to the extent of distributions received upon redemption of their shares[135]. - The company’s initial shareholders control 89.2% of the issued and outstanding ordinary shares, allowing them substantial influence over shareholder votes[153]. - The absence of a specified maximum redemption threshold may enable the company to complete business combinations that a majority of shareholders do not support[151]. - The company’s Articles require a special resolution for amendments, needing at least two-thirds of shareholders' approval, which is a lower threshold compared to some other special purpose acquisition companies[208]. - The company’s ability to amend its Articles may increase the likelihood of completing a business combination that some shareholders may not support[210].